Micki Klearman - 28 Jun 2021 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Issuer symbol
KZR
Transactions as of
28 Jun 2021
Net transactions value
$0
Form type
4
Filing time
30 Jun 2021, 18:48:13 UTC
Previous filing
03 Jun 2021
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Stock Option (Right to Buy) Award $0 +26,000 $0.000000 26,000 28 Jun 2021 Common Stock 26,000 $5.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-hundred percent (100%) of the shares subject to the option shall vest on 6/28/2022, subject to Reporting Person continuing to provide service through such date.